Cannabix Technologies (OTCMKTS:BLOZF) Trading Down 7% - Time to Sell?

Key Points

• Shares fell about 7% mid-day to $0.5507 (low $0.5469) with ~134,192 shares traded, down 48% from the average daily volume of 256,790.
• The company reported quarterly EPS of -$0.01 on just $0.09 million in revenue, and has a market capitalization of $67.44 million with a negative P/E.
• Cannabix develops a handheld THC breathalyzer that aims to provide rapid, non‑invasive detection of recent cannabis use for law enforcement, public safety and workplace testing.

Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) shares were down 7% during mid-day trading on Thursday . The company traded as low as $0.5469 and last traded at $0.5507. Approximately 134,192 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 256,790 shares. The stock had previously closed at $0.5919.

Cannabix Technologies Price Performance

The company has a market capitalization of $67.44 million, a P/E ratio of -27.54 and a beta of 1.04. The firm's 50-day moving average is $0.44 and its 200-day moving average is $0.41.

Cannabix Technologies (OTCMKTS:BLOZF - Get Free Report) last released its quarterly earnings results on Tuesday, December 30th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.09 million during the quarter.

Cannabix Technologies Company Profile

Cannabix Technologies Inc is a Canada-based developer of bio­sensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company's flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.

The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.